Movano (NASDAQ:MOVE – Get Free Report) and QT Imaging (NASDAQ:QTI – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.
Profitability
This table compares Movano and QT Imaging’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Movano | N/A | -345.78% | -198.77% |
QT Imaging | N/A | N/A | -65.94% |
Institutional and Insider Ownership
16.6% of Movano shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 13.4% of Movano shares are owned by insiders. Comparatively, 75.4% of QT Imaging shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Earnings & Valuation
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Movano | $902,000.00 | 35.63 | -$29.28 million | ($5.11) | -0.95 |
QT Imaging | $4.00 million | 3.48 | -$4.03 million | N/A | N/A |
QT Imaging has higher revenue and earnings than Movano.
Volatility & Risk
Movano has a beta of 0.53, suggesting that its share price is 47% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, suggesting that its share price is 120% less volatile than the S&P 500.
Analyst Ratings
This is a summary of current ratings and recommmendations for Movano and QT Imaging, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Movano | 0 | 0 | 1 | 0 | 3.00 |
QT Imaging | 0 | 0 | 0 | 0 | 0.00 |
Movano currently has a consensus price target of $30.00, indicating a potential upside of 519.20%. Given Movano’s stronger consensus rating and higher possible upside, equities analysts plainly believe Movano is more favorable than QT Imaging.
Summary
QT Imaging beats Movano on 6 of the 11 factors compared between the two stocks.
About Movano
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.
About QT Imaging
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.
Receive News & Ratings for Movano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Movano and related companies with MarketBeat.com's FREE daily email newsletter.